Clifford A. Hudis, Md

Biography

Dr. Clifford A. Hudis is a medical oncologist with research interests in all areas of care related to breast cancer. His clinical practice is devoted solely to the treatment of patients with breast cancer; his research is focused on prevention of the disease, prevention of recurrence after surgery, and treatment of recurrences. Working with a broad team of experts at Memorial Sloan Kettering and throughout the world, Hudis is involved in clinical and translational studies that aim to develop better hormone therapies, improved chemotherapy drugs, more-effective and less toxic methods of drug delivery, and newer highly specific agents. Dr. Clifford A. Hudis is a medical oncologist with research interests in all areas of care related to breast cancer. His clinical practice is devoted solely to the treatment of patients with breast cancer; his research is focused on prevention of the disease, prevention of recurrence after surgery, and treatment of recurrences. Working with a broad team of experts at Memorial Sloan Kettering and throughout the world, Hudis is involved in clinical and translational studies that aim to develop better hormone therapies, improved chemotherapy drugs, more-effective and less toxic methods of drug delivery, and newer highly specific agents.

Research Interest

A particular research focus of his team at Memorial Sloan Kettering and collaborators at Weill Cornell Medical College is the interplay between inflammation, obesity, and breast cancer, and they are now actively translating their findings into clinically relevant trials with the potential to reduce the global burden of breast and other cancers. All of the clinical research he is involved with is conducted both at Memorial Sloan Kettering, through the Breast Cancer Disease Management Team and the Breast Cancer Medicine Service, and nationally through several collaborative groups including the Alliance for Clinical Trials in Oncology, where Hudis is Co-Chair of the Breast Cancer Committee, and the Translational Breast Cancer Research Consortium, where he serves on the Steering Committee. In addition, in June 2013 Hudis began a one-year term as President of the American Society of Clinical Oncology (ASCO).